Health Care & Life Sciences » Healthcare Provision | Cryo-Cell International Inc.

Cryo-Cell International Inc. | Balance Sheet

Fiscal year is December-November. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,893.30
3,586.10
4,966.90
4,124.10
6,718.50
6,915.70
Total Accounts Receivable
3,887.20
4,072.00
3,058.40
4,052.70
5,125.60
5,867.30
Inventories
-
-
475.60
361.10
314.60
16,035.90
Other Current Assets
645.00
833.90
1,852.20
473.90
578.30
716.30
Total Current Assets
9,425.50
8,492.00
10,353.10
9,011.90
12,736.90
29,535.20
Net Property, Plant & Equipment
1,207.30
953.40
879.10
979.50
882.40
1,493.40
Total Investments and Advances
721.90
684.00
-
-
-
308
Intangible Assets
56.60
28.40
2,294.20
261.00
226.40
3,282.70
Other Assets
89.50
51.90
40.60
25.50
28.90
113.90
Total Assets
11,500.80
10,209.60
19,497.90
19,538.50
23,910.00
42,390.10
ST Debt & Current Portion LT Debt
-
-
307.40
2,000.00
2,000.00
Accounts Payable
1,194.80
992.90
1,328.60
1,485.40
1,928.50
Income Tax Payable
-
-
-
443.70
356.50
Other Current Liabilities
8,615.60
8,134.30
8,787.90
9,182.60
9,654.80
Total Current Liabilities
9,810.40
9,127.20
10,424.00
13,111.70
13,939.80
Long-Term Debt
-
-
868.90
7,819.80
5,295.20
Deferred Taxes
-
-
5,931.00
9,260.60
10,035.40
Other Liabilities
10,958.40
11,809.10
13,169.20
14,021.30
17,177.90
Total Liabilities
20,768.80
20,936.20
24,462.10
34,952.70
36,412.90
Common Equity (Total)
9,268.00
10,726.70
4,964.20
15,414.30
12,502.90
Total Shareholders' Equity
9,268.00
10,726.70
4,964.20
15,414.30
12,502.90
Total Equity
9,268.00
10,726.70
4,964.20
15,414.30
12,502.90
Liabilities & Shareholders' Equity
11,500.80
10,209.60
19,497.90
19,538.50
23,910.00

About Cryo-Cell International

View Profile
Address
700 Brooker Creek Boulevard
Oldsmar Florida 34677
United States
Employees -
Website http://www.cryo-cell.com
Updated 07/08/2019
Cryo-Cell International, Inc. is cord blood bank engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the Cellular Processing and Cryogenic Storage and Prepacyte CB segments. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use.